المؤلفون: Rachel W. Winter, Mads Israelsen, Manol Jovani, Alison Goldin, Aleksander Krag, Andrew S. Allegretti, Lise Lotte Gluud

المصدر: The Cochrane Library
Israelsen, M, Krag, A, Allegretti, A S, Jovani, M, Goldin, A H, Winter, R W & Gluud, L L 2017, ' Terlipressin versus other vasoactive drugs for hepatorenal syndrome ', Cochrane Database of Systematic Reviews, vol. 2017, no. 9, CD011532 . https://doi.org/10.1002/14651858.CD011532.pub2Test

مصطلحات موضوعية: Medicine General & Introductory Medical Sciences, medicine.medical_specialty, Hepatorenal Syndrome, Lypressin/adverse effects, Dopamine, Midodrine, Lypressin, Octreotide, Placebo, Norepinephrine, 03 medical and health sciences, 0302 clinical medicine, Hepatorenal syndrome, Internal medicine, medicine, Vasoconstrictor Agents, Humans, Pharmacology (medical), 030212 general & internal medicine, Intensive care medicine, Adverse effect, Antihypertensive Agents, Randomized Controlled Trials as Topic, Vasoconstrictor Agents/adverse effects, business.industry, Antihypertensive Agents/adverse effects, Midodrine/therapeutic use, Dopamine/therapeutic use, Norepinephrine/therapeutic use, Octreotide/therapeutic use, medicine.disease, Clinical trial, Meta-analysis, Relative risk, 030211 gastroenterology & hepatology, Hepatorenal Syndrome/drug therapy, business, Terlipressin, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c851f96fb2261499e33852264bb0f72Test
https://doi.org/10.1002/14651858.cd011532.pub2Test

المؤلفون: Tjeerd van Staa, Jan-Willem J. Lammers, Frank de Vries, Hubert G. M. Leufkens, Madelon Bracke, Olaf H. Klungel, S Pouwels

المصدر: British Journal of Clinical Pharmacology, 65(4), 580-6. Wiley

مصطلحات موضوعية: Male, medicine.medical_specialty, Adrenergic beta-Agonists/adverse effects, Myocardial Infarction, Risk Assessment, Drug Safety, Internal medicine, medicine, Humans, Pharmacology (medical), Myocardial infarction, Risk factor, Antihypertensive Agents, Aged, Retrospective Studies, Pharmacology, business.industry, Antihypertensive Agents/adverse effects, Hypertension/drug therapy, Case-control study, Absolute risk reduction, Confounding Factors, Epidemiologic, Myocardial Infarction/chemically induced, Retrospective cohort study, Atrial fibrillation, Odds ratio, Adrenergic beta-Agonists, Middle Aged, medicine.disease, Confounding Factors (Epidemiology), Treatment Outcome, Case-Control Studies, Anesthesia, Hypertension, Female, Risk Assessment/standards, Risk assessment, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::982cabfa269ff083b05672a4bd6c369fTest
https://doi.org/10.1111/j.1365-2125.2007.03077.xTest

المؤلفون: Sjoerd P. van Marle, Gérard Hopfgartner, Herwig Eggers, Cornelia Weber, Jan H. G. Jonkman, Henk W. Viischer, Joseph Meyer, Rita Schmitt, Herbert Birnboeck

المصدر: Journal of clinical pharmacology, Vol. 39, No 7 (1999) pp. 703-714

مصطلحات موضوعية: Endothelin Receptor Antagonists, Male, Gastrointestinal Diseases, Metabolic Clearance Rate, Systole, Antihypertensive Agents/adverse effects/pharmacokinetics, Pyrimidines/blood, Administration, Oral, Blood Pressure, Pharmacology, Placebo, Blood Pressure/drug effects, Sulfonamides/adverse effects/blood/metabolism/pharmacokinetics, Double-Blind Method, Pharmacokinetics, Diastole, Oral administration, Headache/chemically induced, Humans, Medicine, Pharmacology (medical), ddc:610, Antihypertensive Agents, ddc:615, Sulfonamides, Receptors, Endothelin/antagonists & inhibitors, Dose-Response Relationship, Drug, business.industry, Endothelin receptor antagonist, Gastrointestinal Diseases/chemically induced, Headache, Antagonist, Bosentan, respiratory tract diseases, Pyrimidines, Tolerability, Area Under Curve, ddc:500, business, Endothelin receptor, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd6d2e22be897556ce42d871520f0d5Test
https://doi.org/10.1177/00912709922008344Test